Response to Raschi E and colleagues "Reduced reporting of neuropsychiatric adverse events with tumor necrosis factor alpha inhibitors for hidradenitis suppurativa: caution before concluding for risk reduction"

We appreciate the comments of Raschi and colleagues.¹ We agree that the term for interpreting the reporting odds ratio (ROR) in our study² should be "lower than expected reporting of suicidal behaviours with anti‐TNFα drugs" and not "reduced risk". We recognize ^1,2 that the ROR does not offer risk quantification; however, in the spirit of mining for safety signals in the FAERS database, terms that may be interpreted as referring to risk quantification, have been used.³ We thank Raschi and colleagues¹ for highlighting our oversight.